Stockreport

How Analyst Views on Royalty Pharma Are Shifting With Recent Acquisition and Growth Moves [Yahoo! Finance]

Royalty Pharma plc - Class A Ordinary Shares  (RPRX) 
US:NASDAQ Investor Relations: ir.reprosrx.com/investor-relations
PDF This indicates a modestly more optimistic outlook in the wake of its acquisition agreement with XenoTherapeutics. Analysts attribute this upward revision largely to stro [Read more]